bioRxiv · 10.1101/2023.06.16.545157
A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds
Abstract
Current approaches to define chemical-genetic interactions (CGIs) in human cell lines are resource-intensive. We designed a scalable chemical-genetic screen platform by generating a DNA damage response (DDR)-focused custom sgRNA library. We performed five proof-of-principle compound screens and found that the compounds known modes-of-action (MoA) were enriched among the compounds CGIs. These scalable screens recapitulated expected CGIs at a comparable signal-to-noise ratio (SNR) relative to genome-wide screens. Furthermore, time-resolved CGIs, captured by sequencing screens at various time points, suggested an unexpected, late time point interstrand-crosslinking (ICL) repair pathway response to camptothecin-induced DNA damage. Our approach can facilitate screening compounds at scale and produce biologically informative CGI profiles.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Lin, K., Chang, Y.-C., Billmann, M., Ward, H. N., Le, K., Hassan, A. Z., Bhojoo, U., Chan, K., Costanzo, M., Moffat, J., Boone, C., Bielinsky, A.-K., Myers, C. L.. 2023-06-16. A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. https://doi.org/10.1101/2023.06.16.545157
Cite the original work for its findings. Save a collection to share your selection of sources.